Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Malignant Melanoma of Skin AJCC V6”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03698019
What this trial is testing

Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma

Who this might be right for
Acral Lentiginous MelanomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+1 more
National Cancer Institute (NCI) 313
Testing effectiveness (Phase 2)Active Not RecruitingNCT04645680
What this trial is testing

Diet and Immune Effects Trial: DIET- A Randomized Double Blinded Dietary Intervention Study in Patients With Metastatic Melanoma Receiving Immunotherapy

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Melanoma+7 more
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Looking for participantsNCT05896839
What this trial is testing

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+10 more
National Cancer Institute (NCI) 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT03719131
What this trial is testing

Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy

Who this might be right for
Cutaneous Melanoma, Stage IIICutaneous Melanoma, Stage IVStage III Melanoma+5 more
Emory University 15
Early research (Phase 1)Study completedNCT00090896
What this trial is testing

CP-675,206 (CTLA4-Blocking Monoclonal Antibody) Combined With Dendritic Cell Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery

Who this might be right for
Melanoma (Skin)
Jonsson Comprehensive Cancer Center 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT02858921
What this trial is testing

Neoadjuvant Dabrafenib, Trametinib and/or Pembrolizumab in BRAF Mutant Resectable Stage III Melanoma

Who this might be right for
Melanoma
Melanoma Institute Australia 60
Large-scale testing (Phase 3)Ended earlyNCT01875653
What this trial is testing

Autologous Dendritic Cell-Tumor Cell Immunotherapy for Metastatic Melanoma

Who this might be right for
Stage IV MelanomaStage III Melanoma
Lisata Therapeutics, Inc. 4
Testing effectiveness (Phase 2)WithdrawnNCT04995094
What this trial is testing

Study of Neoadjuvant Imprime PGG and Pembrolizumab for Stage III, Resectable Melanoma

Who this might be right for
Pathologic Stage III Cutaneous Melanoma AJCC v8
HiberCell, Inc.
Not applicableLooking for participantsNCT06508775
What this trial is testing

Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies

Who this might be right for
Melanoma Stage IIIB-cell Non Hodgkin LymphomaPediatric ALL+4 more
Miltenyi Biomedicine GmbH 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT02965716
What this trial is testing

Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma

Who this might be right for
Advanced MelanomaRecurrent MelanomaStage III Cutaneous Melanoma AJCC v7+5 more
National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Study completedNCT00002973
What this trial is testing

Melphalan and Whole-Body Hyperthermia in Treating Patients With Advanced Melanoma

Who this might be right for
Melanoma (Skin)
University of Wisconsin, Madison 34
Testing effectiveness (Phase 2)Study completedNCT00003339
What this trial is testing

Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
University of Southern California 48
Early research (Phase 1)Study completedNCT00104845
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Memorial Sloan Kettering Cancer Center 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT03235245
What this trial is testing

Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and Binimetinib

Who this might be right for
Unresectable Stage III MelanomaStage IV Melanoma
European Organisation for Research and Treatment of Cancer - EORTC 271
Testing effectiveness (Phase 2)Study completedNCT00003989
What this trial is testing

ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma

Who this might be right for
Lung CancerMelanoma (Skin)
European Organisation for Research and Treatment of Cancer - EORTC 50
Not applicableUnknownNCT06299878
What this trial is testing

MelPRO-0322 (CRISTINA Trial) [miCrobiome pRedIctS aPD1 effecTivnes In melaNoma pAtietns]

Who this might be right for
Melanoma, SkinMelanoma Stage Iii
Russian Academy of Medical Sciences 72
Large-scale testing (Phase 3)Study completedNCT00004196
What this trial is testing

Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis

Who this might be right for
Melanoma (Skin)
University of Alabama at Birmingham 3,000
Testing effectiveness (Phase 2)Study completedNCT02304458
What this trial is testing

Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas

Who this might be right for
Metastatic MelanomaRecurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorRecurrent Hodgkin Lymphoma+20 more
National Cancer Institute (NCI) 140
Early research (Phase 1)Study completedNCT00025181
What this trial is testing

Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
University of Southern California 19
Early research (Phase 1)Ended earlyNCT01940809
What this trial is testing

Ipilimumab With or Without Dabrafenib, Trametinib, and/or Nivolumab in Treating Patients With Melanoma That Is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
BRAF V600E Mutation PresentBRAF V600K Mutation PresentMetastatic Melanoma+5 more
National Cancer Institute (NCI) 15
Next Page